News

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units
Detailed price information for Innocan Pharma Corp (INNPF) from The Globe and Mail including charting and trades.
LSL PHARMA GROUP ANNOUNCES THE SIGNING OF TWO AGREEMENTS TO MARKET NEW OPHTHALMIC PRODUCTS IN CANADA
GROUPE LSL PHARMA INC (TSXV: LSL) (TSXV: LSL.DB) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical ...
Business Insider27d
NVIDIA Launches Family of Open Reasoning AI Models for Developers and Enterprises to Build Agentic AI Platforms
Post-Trained by NVIDIA, New Llama Nemotron Reasoning Models Provide Business-Ready Foundation for Agentic AI Accenture, Amdocs, Atlassian, Box, Cadence, CrowdStrike, Deloitte, IQVIA, Microsoft ...
Biocon Biologics Ltd.: Biocon Biologics Announces U.S. FDA Approval for Jobevne, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio
BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...
manilatimes26d
NVIDIA Launches Family of Open Reasoning AI Models for Developers and Enterprises to Build Agentic AI Platforms
Post-Trained by NVIDIA, New Llama Nemotron Reasoning Models Provide Business-Ready Foundation for Agentic AI Accenture, Amdocs, Atlassian, Box, Cadence, CrowdStrike, Deloitte, IQVIA, Microsoft ...
Iqvia price target lowered to $190 from $235 at BofA
BofA lowered the firm’s price target on Iqvia (IQV) to $190 from $235 and keeps a Buy rating on the shares. Sentiment for Life Sciences and ...
IQVIA Holdings Inc. stock rises Friday, still underperforms market
IQVIA Holdings Inc. closed 42.44% below its 52-week high of $252.88, which the company reached on August 29th.
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors
Shares of IQVIA Holdings Inc. IQV slipped 8.79% to $143.22 Thursday, on what proved to be an all-around poor trading session ...